Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238)

NCT01244828 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
157
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Organon and Co